Nr601 Week 5 Part 2 Study Guide: Glucose Metabolism Disorders And Diabetes Types

Name: Nr601 Week 5 Study Guide: Glucose Metabolism & Diabetes
Brand: MarkschemePDFMarket
SKU: PDF-BUS-1222
Price: 16.00 USD
Availability: InStock

Master Type 1, Type 2, And Gestational Diabetes With This Nr601 Study Guide Covering Diagnostic Criteria And Initial Treatment.

$16.00

Description

Gain a comprehensive understanding of glucose metabolism disorders through targeted revision of diabetes types and clinical management. This resource consolidates essential knowledge on the pathophysiology, diagnosis, and initial therapeutic interventions for Type 1, Type 2, and Gestational Diabetes Mellitus. It provides clear guidance on diagnostic thresholds such as fasting plasma glucose levels and HbA1c percentages to enhance exam readiness. The content supports confident decision-making regarding screening protocols and pharmacological options like biguanides.

PDF Sample

1 / 3

NR601 Week 5 Study Guide: Glucose Metabolism & Diabetes IMG-1

NR601 Week 5 Study Guide: Glucose Metabolism & Diabetes IMG-2

NR601 Week 5 Study Guide: Glucose Metabolism & Diabetes IMG-3

Sample Pages

Who is this Document for ?

This document is designed for nursing students enrolled in advanced pathophysiology courses, specifically those studying NR601. It is suitable for exam candidates preparing for weekly assessments on endocrine system disorders. Tutors and clinical instructors may also use this material to reinforce key concepts regarding diabetes management during teaching sessions.

What you will learn ?

⬤Distinguish between Type 1, Type 2, and Gestational Diabetes by analysing their onset age, prevalence rates, and underlying insulin mechanisms such as lack of production versus resistance.

⬤Apply specific diagnostic criteria for hyperglycaemia, including identifying critical thresholds for fasting plasma glucose (126 mg/dL) and oral glucose tolerance test results (200 mg/dL).

⬤Evaluate the role of Haemoglobin A1c levels in primary diagnosis and understand the clinical implications of values exceeding 6.5% for patient management.

⬤Implement recommended screening protocols as outlined by the American Diabetes Association, targeting routine testing at age 45 and earlier intervention for those with risk factors like obesity or family history.

⬤Identify appropriate initial pharmacological treatments for Type 2 diabetes in patients with overweight or obesity classifications (BMI 25-30 kg/m²), specifically recognising biguanides as a first-line therapy option.

What do you get with this PDF ?

⬤ Instant access after purchase

⬤ Download in PDF format

⬤ DRM free, read anywhere

Document details

Last update :

Aug 23, 2026

Length :

10 pages

Edition :

Language :

English